Magellan Health (NASDAQ:MGLN) vs. Its Competitors Head to Head Survey

Magellan Health (NASDAQ: MGLN) is one of 14 publicly-traded companies in the “Managed Health Care” industry, but how does it contrast to its peers? We will compare Magellan Health to related businesses based on the strength of its profitability, analyst recommendations, earnings, valuation, institutional ownership, risk and dividends.

Volatility and Risk

Magellan Health has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. Comparatively, Magellan Health’s peers have a beta of 0.76, meaning that their average share price is 24% less volatile than the S&P 500.

Profitability

This table compares Magellan Health and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Magellan Health 1.59% 8.88% 4.08%
Magellan Health Competitors 1.70% 10.53% 3.41%

Valuation and Earnings

This table compares Magellan Health and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Magellan Health $5.28 billion $242.58 million 24.21
Magellan Health Competitors $52.30 billion $3.74 billion 17.82

Magellan Health’s peers have higher revenue and earnings than Magellan Health. Magellan Health is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Analyst Ratings

This is a summary of current ratings and price targets for Magellan Health and its peers, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Magellan Health 1 0 3 0 2.50
Magellan Health Competitors 79 872 1431 22 2.58

Magellan Health currently has a consensus target price of $81.25, suggesting a potential downside of 4.92%. As a group, “Managed Health Care” companies have a potential upside of 0.84%. Given Magellan Health’s peers stronger consensus rating and higher probable upside, analysts plainly believe Magellan Health has less favorable growth aspects than its peers.

Institutional & Insider Ownership

93.6% of Magellan Health shares are owned by institutional investors. Comparatively, 90.2% of shares of all “Managed Health Care” companies are owned by institutional investors. 3.6% of Magellan Health shares are owned by company insiders. Comparatively, 2.5% of shares of all “Managed Health Care” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Magellan Health peers beat Magellan Health on 8 of the 13 factors compared.

About Magellan Health

Magellan Health, Inc. is engaged in the healthcare management business. The Company’s segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC). Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists primarily of operational support functions. It provides services to health plans and other managed care organizations (MCOs).

Receive News & Ratings for Magellan Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Magellan Health Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Houston’s Dallas Keuchel Could Make Relief Appearance in Game 7
Houston’s Dallas Keuchel Could Make Relief Appearance in Game 7
Houston Astros Relying on Justin Verlander to Save Their Season
Houston Astros Relying on Justin Verlander to Save Their Season
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Aaron Judge and Gary Sanchez Have Break Out Games
Aaron Judge and Gary Sanchez Have Break Out Games
Justin Turner Joining Postseason Legends
Justin Turner Joining Postseason Legends
PED Use Cost Alex Rodriguez Millions and His Reputation
PED Use Cost Alex Rodriguez Millions and His Reputation


Leave a Reply

 
© 2006-2017 BBNS.